{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:37:16Z","timestamp":1790797036068,"version":"4.1.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,6,12]],"date-time":"2013-06-12T00:00:00Z","timestamp":1370995200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1007\/s11102-013-0497-x","type":"journal-article","created":{"date-parts":[[2013,6,11]],"date-time":"2013-06-11T09:13:00Z","timestamp":1370941980000},"page":"246-250","source":"Crossref","is-referenced-by-count":28,"title":["Male prolactinomas presenting with normal testosterone levels"],"prefix":"10.1007","volume":"17","author":[{"given":"Ilan","family":"Shimon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Benbassat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,6,12]]},"reference":[{"key":"497_CR1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11102-005-5084-3","volume":"8","author":"A Ciccarelli","year":"2005","unstructured":"Ciccarelli A, Guerra E, De Rosa M, Milone F, Zarrilli S, Lombardi G, Colao A (2005) PRL secreting adenomas in male patients. Pituitary 8:39\u201342","journal-title":"Pituitary"},{"key":"497_CR2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1385\/ENDO:20:1-2:75","volume":"20","author":"M Rosa De","year":"2003","unstructured":"De Rosa M, Zarrilli S, Di Sarno A, Milano N, Gaccione M, Boggia B, Lombardi G, Colao A (2003) Hyperprolactinemia in men: clinical and biochemical features and response to treatment. Endocrine 20:75\u201382","journal-title":"Endocrine"},{"key":"497_CR3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11102-010-0251-6","volume":"14","author":"I Shimon","year":"2011","unstructured":"Shimon I, Benbassat C, Tzvetov G, Grozinsky-Glasberg S (2011) Anemia in a cohort of men with macroprolactinomas: increase in hemoglobin levels follows prolactin suppression. Pituitary 14:11\u201315","journal-title":"Pituitary"},{"key":"497_CR4","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/ncpendmet0160","volume":"2","author":"A Colao","year":"2006","unstructured":"Colao A, Di Sarno A, Guerra E, De Leo M, Mentone A, Lombardi G (2006) Drug insight: cabergoline and bromocriptine in the treatment of hyperprolactinemia in men and women. Nat Clin Pract Endocrinol Metab 2:200\u2013210","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"497_CR5","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1210\/er.2005-9998","volume":"27","author":"MP Gillman","year":"2006","unstructured":"Gillman MP, Molitch ME, Lombardi G, Colao A (2006) Advances in the treatment of prolactinomas. Endocr Rev 27:485\u2013534","journal-title":"Endocr Rev"},{"key":"497_CR6","first-page":"3053","volume":"85","author":"JJ Pinzone","year":"2000","unstructured":"Pinzone JJ, Katznelson L, Danila DC, Pauler DK, Miller CS, Klibanski A (2000) Primary medical therapy of micro- and macroprolactinomas in men. J Clin Endocrinol Metab 85:3053\u20133057","journal-title":"J Clin Endocrinol Metab"},{"key":"497_CR7","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1210\/jc.2003-030979","volume":"89","author":"A Colao","year":"2004","unstructured":"Colao A, Vitale G, Cappabianca P, Briganti F, Ciccarelli A, De Rosa M, Zarrilli S, Lombardo G (2004) Outcome of cabergoline treatment in men with prolactinoma: effect of a 24-month treatment on prolactin levels, tumor mass, recovery of pituitary function, and semen analysis. J Clin Endocrinol Metab 89:1704\u20131711","journal-title":"J Clin Endocrinol Metab"},{"key":"497_CR8","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1530\/EJE-06-0646","volume":"156","author":"I Shimon","year":"2007","unstructured":"Shimon I, Benbassat C, Hadani M (2007) Effectiveness of long-term cabergoline treatment for giant prolactinomas: study of 12 men. Eur J Endocrinol 156:225\u2013231","journal-title":"Eur J Endocrinol"},{"key":"497_CR9","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/BF03349742","volume":"18","author":"M Berezin","year":"1995","unstructured":"Berezin M, Shimon I, Hadani M (1995) Prolactinoma in 53 men: clinical characteristics and modes of treatment (male prolactinoma). J Endocrinol Invest 18:436\u2013441","journal-title":"J Endocrinol Invest"},{"key":"497_CR10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/BF03345523","volume":"28","author":"EC Naliato","year":"2005","unstructured":"Naliato EC, Farias ML, Braucks GR, Costa FS, Zylberberg D, Violante AH (2005) Prevalence of osteopenia in men with prolactinoma. J Endocrinol Invest 28:12\u201317","journal-title":"J Endocrinol Invest"},{"key":"497_CR11","doi-asserted-by":"crossref","first-page":"4721","DOI":"10.1210\/jc.2007-2758","volume":"93","author":"M Ono","year":"2008","unstructured":"Ono M, Miki N, Kawamata T, Makino R, Amano K, Seki T, Kubo O, Hori T, Takano K (2008) Prospective study of high-dose cabergoline treatment of prolactinomas in 150 patients. J Clin Endocrinol Metab 93:4721\u20134727","journal-title":"J Clin Endocrinol Metab"},{"key":"497_CR12","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2265.2012.04351.x","volume":"77","author":"P Iglesias","year":"2012","unstructured":"Iglesias P, Bernal C, Villabona C, Castro JC, Arrieta F, D\u00edez JJ (2012) Prolactinomas in men: a multicentre and retrospective analysis of treatment outcome. Clin Endocrinol (Oxf) 77:281\u2013287","journal-title":"Clin Endocrinol (Oxf)"},{"key":"497_CR13","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1023\/A:1025377816769","volume":"5","author":"L Sibal","year":"2002","unstructured":"Sibal L, Ugwu P, Kendall-Taylor P, Ball SG, James RA, Pearce SH, Hall K, Quinton R (2002) Medical therapy of macroprolactinomas in males: I. Prevalence of hypopituitarism at diagnosis. II. Proportion of cases exhibiting recovery of pituitary function. Pituitary 5:243\u2013246","journal-title":"Pituitary"},{"key":"497_CR14","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1055\/s-0032-1333232","volume":"121","author":"CA Elenkova","year":"2013","unstructured":"Elenkova CA, Genov N, Abadzhieva Z, Kirilov G, Vasilev V, Kalinov K, Zacharieva S (2013) Macroprolactinemia in patients with prolactinomas: prevalence and clinical significance. Exp Clin Endocrinol Diabetes 121:201\u2013205","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"497_CR15","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s12020-011-9536-4","volume":"41","author":"G Tamer","year":"2012","unstructured":"Tamer G, Telci A, Mert M, Uzum AK, Aral F, Tanakol R, Yarman S, Boztepe H, Colak N, Alag\u00f6l F (2012) Prevalence of pituitary adenomas in macroprolactinemic patients may be higher than it is presumed. Endocrine 41:138\u2013143","journal-title":"Endocrine"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-013-0497-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11102-013-0497-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-013-0497-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T06:08:17Z","timestamp":1559369297000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11102-013-0497-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,12]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["497"],"URL":"https:\/\/doi.org\/10.1007\/s11102-013-0497-x","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,12]]}}}